Live feed
Filing
SC 13G
SC 13G0000919574-19-000647·ARMISTICE CAPITAL, LLC
Schedule 13G ownership disclosure
Sunesis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 867328700
Event date: 2019-01-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-000647
- Form type
- SC 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Jan 28, 2019
- Reporting period
- Jan 18, 2019
- Description
- Schedule 13G beneficial ownership